Jobs at Click Therapeutics
249,921 open positions
Senior Specialist, Drug Safety & Pharmacovigilance
Company: Corcept Therapeutics
Location: Peninsula
Posted Apr 14, 2023
Corcept is a commercial-stage company that has marketed Korlym for the treatment of Cushing's syndrome and is developing new treatments for various disorders. The company has generated revenue and is planning to initiate new trials.
Manager/Senior Manager, Business Analytics
Company: Corcept Therapeutics
Location: Peninsula
Posted Apr 14, 2023
Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders. The company has generated revenue of $402 million and net income of $101 million in 2022. They have discovered a portfolio of over 1,000 proprietary selective cortisol modulators and are in various phases of clinical trials for different disorders.
Principal/Associate Director, Research Informatics
Company: Photys Therapeutics
Location: Waltham
Posted Apr 14, 2023
The text describes a job opportunity for a Principal/Associate Director of Research Informatics at Photys, an early-stage biotechnology company. The role involves developing, implementing, and maintaining ELN/LIMS and reporting/analytics systems, collaborating with the R&D team, and managing vendor and consultant relationships. The ideal candidate should have a Bachelor's Degree in Life Sciences, Information Technology, or a related discipline, 5-7 years of experience in building and implementing data models, and experience with scientific data management platforms. The company offers total rewards including competitive medical and dental coverage, PTO, HSA, Dependent Care Account, and 401K with match.
Account Executive
Company: Force Therapeutics
Location: Other US Location
Posted Apr 14, 2023
Force Therapeutics is a leading digital care provider with a SaaS-based platform used by over 700,000 patients for post-surgery recovery. They serve various clients including Academic Medical Centers, ASC, and large PE-backed practices. Their platform has been validated in 145 studies by surgeon leaders. They are seeking an experienced Account Executive to join their growing team and sell their platform to new organizations.
Associate Scientist/Senior Research Associate, Downstream Development
Company: Shape Therapeutics
Location: Seattle, WA
Posted Apr 13, 2023
ShapeTX is a pioneering biotech company developing innovative RNA medicines to treat genetic diseases. They are seeking a Senior Research Associate to work on downstream development, including purification processes for viral vectors. The company offers a competitive benefits package and a commitment to fostering an inclusive environment.
Scientist I/II, Discovery Liver
Company: Scribe Therapeutics
Location: East Bay
Posted Apr 14, 2023
Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. They are seeking a highly creative, passionate, and motivated individual to join their team in developing the next generation of CRISPR-based therapeutics. The candidate should have a passion for working collaboratively with biologists and bioengineers and expertise in studying metabolic and liver disorders.
Scientist I/II, Discovery Liver
Company: Scribe Therapeutics
Location: East Bay
Posted Apr 14, 2023
Scribe Therapeutics, a molecular engineering company founded by CRISPR inventors, is seeking a Scientist, Discovery Liver to join their team. The candidate should have a PhD in cell biology, physiology, molecular biology, or equivalent, and expertise in in vitro hepatocyte models and assays. The role involves working on therapeutic strategy, executing early stage research, and collaborating with a team to develop CRISPR-based therapeutics. The company offers professional growth opportunities, a competitive salary, and a diverse, inclusive environment.
Research Associate/Senior Research Associate (Bioanalytical Sciences)
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 14, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with innovative expertise in capsid discovery and deep neuropharmacology. The company's TRACER AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration. Voyager's pipeline includes preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The company is seeking a Research Associate to contribute to their Bioanalytical Sciences team in Cambridge, Massachusetts.
Associate Scientist, Analytical Development
Company: Shape Therapeutics
Location: Seattle, WA
Posted Apr 13, 2023
ShapeTX is a pioneering biotech company developing innovative RNA medicines to treat genetic diseases. They are seeking an Associate Scientist, Analytical Development to work on AAV analysis techniques and support process development. The company offers a competitive benefits package and a salary range of $82,000 - $110,000.
Senior Research Associate, Translational Research (Bioanalytical Sciences)
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 14, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with innovative expertise in capsid discovery and deep neuropharmacology capabilities. The company's TRACER AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration. Voyager's pipeline includes preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS), with validated targets and biomarkers. The company is seeking a Senior Research Associate to contribute to their Bioanalytic Sciences team in Cambridge, Massachusetts.
Senior Specialist, Drug Safety & Pharmacovigilance
Company: Corcept Therapeutics
Location: Peninsula
Posted Apr 14, 2023
Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. The company has generated revenue of $402 million and net income of $101 million in 2022. They have discovered a portfolio of over 1,000 proprietary selective cortisol modulators, with lead compounds in Phase 2 and Phase 3 trials for various treatments. The company plans to initiate a Phase 2b trial in patients with non-alcoholic steatohepatitis by the end of the year. They expect to submit several new drug applications in the next few years.